文献速递瓣膜外科

开放性二尖瓣交界分离术与机械瓣置换术治疗风湿性二尖瓣狭窄的长期结局比较

Long-Term Outcomes of Open Mitral Commissurotomy vs Mechanical Mitral Valve Replacement in Rheumatic Mitral Stenosis.
PubMed 文献 · Ann Thorac Surg · 2026-03-20

该回顾性队列研究纳入1995至2021年249例严重风湿性二尖瓣狭窄患者,比较开放性二尖瓣交界分离术(n=58)与机械瓣置换术(n=191)的长期结局。经倾向性评分匹配后,20年复合终点发生率两组相似,但交界分离术组大出血更少且无感染性心内膜炎发生。

要点

  • 严重风湿性二尖瓣狭窄患者中,开放性交界分离术与机械瓣置换术的20年复合终点发生率相似。
  • 开放性交界分离术组大出血发生率显著低于机械瓣置换术组,且无感染性心内膜炎发生。
  • 交界分离术组再手术率有偏高趋势但未达统计学显著性,二尖瓣面积和跨瓣压差长期改善。

核心结论

  • 在严重风湿性二尖瓣狭窄患者中,开放性二尖瓣交界分离术提供与机械瓣置换术相当的长期临床结局。
  • 开放性交界分离术与大出血事件更少及无感染性心内膜炎相关。
  • 研究结果支持开放性交界分离术作为特定患者合理的保留瓣膜选择。

研究设计与样本

  • 回顾性分析1995至2021年249例因严重风湿性二尖瓣狭窄行二尖瓣手术的患者。
  • 开放性二尖瓣交界分离术组58例,机械瓣置换术组191例。
  • 采用倾向性评分匹配校正基线差异,平均随访11.4±7.0年。

主要发现

  • 感染性心内膜炎仅见于机械瓣置换术后(0% vs 2.4%)。

临床怎么用

  • 对于严重风湿性二尖瓣狭窄的特定患者,开放性二尖瓣交界分离术可作为保留自体瓣膜的合理选择。
  • 选择开放性交界分离术时需权衡再手术风险与大出血及感染性心内膜炎风险降低的获益。

局限性

  • 本研究为单中心回顾性分析,样本量有限,可能存在选择偏倚。
  • 开放性交界分离术组样本量较小(n=58),可能影响部分结局的统计效能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mechanical mitral valve replacement (MVR) is widely performed for severe rheumatic mitral stenosis (MS) but requires lifelong anticoagulation and carries prosthesis-related risks. Open mitral commissurotomy offers a valve-preserving alternative, yet contemporary long-term data are scarce. We compared long-term outcomes of open mitral commissurotomy and MVR in severe MS. METHODS: We retrospectively analyzed 249 patients undergoing mitral valve surgery for severe rheumatic MS (1995-2021): open mitral commissurotomy (n = 58) and MVR (n = 191). The primary outcome was a composite of all-cause death, mitral valve reoperation, major bleeding, stroke, heart failure readmission, and infective endocarditis. Propensity score matching adjusted for baseline differences. RESULTS: Mean follow-up was 11.4 ± 7.0 years. In the matched cohort, 20-year composite outcome incidence was similar between open mitral commissurotomy and MVR (36.9% vs 44.6%; subdistribution hazard ratio (sHR), 0.78; 95% CI, 0.42-1.45; P = .429). Major bleeding was lower with open mitral commissurotomy (4.4% vs 22.5%; sHR, 0.22; P = .047), and infective endocarditis occurred only after MVR (0% vs 2.4%). Mitral valve reoperation tended to be more frequent in the open mitral commissurotomy group (16.7% vs 5.7%; sHR, 3.04; P = .137), but the difference was not statistically significant. In open mitral commissurotomy, mitral valve area increased from 0.90 ± 0.14 cm2 preoperatively to 1.56 ± 0.31 cm2 at 15 years (P < .001), and transmitral pressure gradient decreased from 11.4 ± 7.3 mm Hg to 4.6 ± 1.9 mm Hg (P < .001). CONCLUSIONS: In patients with severe MS, open mitral commissurotomy provides comparable long-term clinical outcomes to MVR and is associated with fewer bleeding events and no infective endocarditis. These findings support open mitral commissurotomy as a reasonable valve-preserving option in selected patients.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Park I, Ahn JH, Sung K, et al. Long-Term Outcomes of Open Mitral Commissurotomy vs Mechanical Mitral Valve Replacement in Rheumatic Mitral Stenosis. Ann Thorac Surg. 2026. PMID: 41865964. doi:10.1016/j.athoracsur.2026.03.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。